Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q0Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,275
Award facts
- Contract value 100% obligated
- $39,275.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for $39.3K to supply DESCOVY 200-25 mg tablets (30-count units) with a completion date of December 17, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs.
This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, delivering brand-name and generic medications to support military healthcare programs. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the breadth of therapeutic domains covered under the company's federal contracts. The firm fixed-price structure and competitive award status demonstrate AmerisourceBergen's capability to meet federal procurement requirements through open competition, consistent with its established track record of fulfilling diverse pharmaceutical and medical supply needs across multiple therapeutic categories for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q0Y?
SPE2DR26F9Q0Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F9Q0Y worth?
The government has obligated $39,275 on SPE2DR26F9Q0Y.
Is contract SPE2DR26F9Q0Y an order under another contract?
Yes. SPE2DR26F9Q0Y is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q0Y competed?
The extent of competition for SPE2DR26F9Q0Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award